(Q36134686)

12 August 2017

Tallimustine in advanced previously untreated colorectal cancer, a phase II study (English)

1 reference

12 August 2017

1 reference

1 reference

Punt CJ

1

1 reference

12 August 2017

Humblet Y

2

1 reference

12 August 2017

Roca E

3

1 reference

12 August 2017

Dirix LY

4

1 reference

12 August 2017

Wainstein R

5

1 reference

12 August 2017

Polli A

6

1 reference

12 August 2017

Corradino I

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

73

1 reference

12 August 2017

6

1 reference

12 August 2017

803-804

1 reference

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

Selective DNA interaction of the novel distamycin derivative FCE 24517.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074363

Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cells

2 July 2018

1 reference

12 December 2020

The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents

1 reference

12 December 2020

The unique interaction with immunity of FCE 24517, an antitumor drug with a novel mode of action

1 reference

12 December 2020

Phase I study of the novel distamycin derivative tallimustine (FCE 24517)

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.140

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8611384

1 reference